Lam Research (LRCX) Tops Q4 EPS by 56c; offers guidance

Lam Research (NASDAQ: LRCX) reported Q4 EPS of $8.14, $0.56 better than the analyst estimate of $7.58. Revenue for the quarter came in at $3.87 billion versus the consensus estimate of $3.82 billion.

GUIDANCE:

Lam Research sees Q1 2025 EPS of $8.00 +/-$0.75, versus the consensus of $8.02. Lam Research sees Q1 2025 revenue of $4.05 billion +/-$300 Million, versus the consensus of $4.03 billion.

For earnings history and earnings-related data on Lam Research (LRCX) click here.

You May Also Be Interested In

• Lam Research (LRCX) PT Raised to $400 at TD Cowen
• Rani Therapeutics and PegBio enter obesity drug collaboration
• Lam Research (LRCX) PT Raised to $400 at Mizuho